Impact of Intratumoral Inflammation on Survival After Pancreatic Cancer Resection
- PMID: 26474423
- PMCID: PMC4850490
- DOI: 10.1097/MPA.0000000000000423
Impact of Intratumoral Inflammation on Survival After Pancreatic Cancer Resection
Abstract
Objectives: Pancreatic cancer (PaC) frequently results in death despite surgical resection. We sought to evaluate whether inflammation in the primary tumor was associated with early death after surgical resection.
Methods: In this case-control study, we identified 21 individuals who died less than 12 months after surgery for PaC and 42 controls who survived more than 36 months after surgery. Differences in the composition of host inflammatory response between the groups were evaluated with univariate comparisons and odds ratios for early death were calculated using logistic regression modeling.
Results: Cases were more likely to have a high tumor grade (90.5% vs 26.2%; P < 0.01). The odds of early death were increased in those with a high-grade tumor (unadjusted odds ratio, 26.77; 95% confidence interval, 5.35-134.07; P < 0.01). Conversely, the density (high vs low) of inflammatory cells in tumors was similar between the groups, and odds of early death were not associated with any inflammatory marker.
Conclusions: High tumor grade, but not altered density of inflammatory cells in the intratumoral compartment, is associated with increased odds of early death after PaC resection. Future studies evaluating the host response in multiple tumor compartments with advanced histologic techniques is needed to further elucidate the role of inflammation in PaC.
Conflict of interest statement
Similar articles
-
Long-term survival after resection of pancreatic cancer: a single-center retrospective analysis.World J Gastroenterol. 2015 Jan 7;21(1):262-8. doi: 10.3748/wjg.v21.i1.262. World J Gastroenterol. 2015. PMID: 25574100 Free PMC article.
-
In-hospital mortality after pancreatic resection for chronic pancreatitis: population-based estimates from the nationwide inpatient sample.J Am Coll Surg. 2009 Oct;209(4):468-76. doi: 10.1016/j.jamcollsurg.2009.05.030. Epub 2009 Aug 20. J Am Coll Surg. 2009. PMID: 19801320
-
Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinoma.World J Surg Oncol. 2014 Nov 27;12:360. doi: 10.1186/1477-7819-12-360. World J Surg Oncol. 2014. PMID: 25429841 Free PMC article.
-
Total pancreatectomy for pancreatic ductal adenocarcinoma: review of the National Cancer Data Base.HPB (Oxford). 2016 Jan;18(1):21-8. doi: 10.1016/j.hpb.2015.07.009. Epub 2015 Dec 21. HPB (Oxford). 2016. PMID: 26776847 Free PMC article. Review.
-
Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis.World J Gastroenterol. 2015 Mar 7;21(9):2807-15. doi: 10.3748/wjg.v21.i9.2807. World J Gastroenterol. 2015. PMID: 25759553 Free PMC article. Review.
Cited by
-
Reg proteins promote acinar-to-ductal metaplasia and act as novel diagnostic and prognostic markers in pancreatic ductal adenocarcinoma.Oncotarget. 2016 Nov 22;7(47):77838-77853. doi: 10.18632/oncotarget.12834. Oncotarget. 2016. PMID: 27788482 Free PMC article.
-
Correlation of intratumoral mast cell quantity with psychosocial distress in patients with pancreatic cancer: the PancStress study.Sci Rep. 2024 Nov 1;14(1):26285. doi: 10.1038/s41598-024-77010-8. Sci Rep. 2024. PMID: 39487177 Free PMC article.
-
Evaluation of tumor budding, desmoplastic reaction, and lymphocytic infiltration in predicting survival for pancreatic ductal adenocarcinoma.World J Gastrointest Oncol. 2025 Jun 15;17(6):107021. doi: 10.4251/wjgo.v17.i6.107021. World J Gastrointest Oncol. 2025. PMID: 40547151 Free PMC article.
-
Inflammation, Biomarkers and Immuno-Oncology Pathways in Pancreatic Cancer.J Pers Med. 2019 Apr 26;9(2):20. doi: 10.3390/jpm9020020. J Pers Med. 2019. PMID: 31035449 Free PMC article.
-
Advances in pancreatic cancer biomarkers.Oncol Rev. 2019 Feb 1;13(1):410. doi: 10.4081/oncol.2019.410. eCollection 2019 Jan 14. Oncol Rev. 2019. PMID: 31044028 Free PMC article.
References
-
- Siegel R, Ma J, Zou Z, et al. CA Cancer J Clin. 2014;64:9–29. - PubMed
-
- Barugola G, Partelli S, Marcucci S, et al. Resectable pancreatic cancer: who really benefits from resection? Ann Surg Oncol. 2009;16:3316–22. - PubMed
-
- Greer JB, Whitcomb DC. Inflammation and pancreatic cancer: an evidence-based review. Curr Opin Pharmacol. 2009;9:411–8. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical